ArticleOncoimmunology

Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy.

Simon Schliffke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.